Clinical Trials · NCT06983171
Semaglutide Effectiveness in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease in the Real World Practice
- Phase
- N/A
- Recruitment status
- Active Not Recruiting
- Sponsor
- Center of target therapy
- Enrollment
- 70
- Start date
- Apr 2025
- Locations
- 1 site, Russia
- Primary endpoint
- Evaluate the impact of semaglutide therapy on liver morphological changes based on liver histology using the NAFLD Activity Score (NAS).